Study of liver disease and genes in people with fatty liver
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study collects information about metabolic and unexplained (cryptogenic) liver disease and looks at “omics” tests, which are lab tests that measure patterns in blood or tissue to learn what drives the disease. It may help researchers better understand fatty liver and related serious complications, like liver scarring and liver cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older.
- You have fatty liver disease (NAFLD) such as simple fat buildup, NASH, metabolic cirrhosis, or NAFLD-related liver cancer—confirmed by biopsy or blood/imaging tests.
- Your alcohol intake is low (no more than 21 units/week for men or 14 units/week for women) in the last 6 months, and you do not have a past history of heavy drinking over the last 5 years.
- Either you had hepatitis C (HCV) treated with new medicines and have been virus-free for more than 6 months, or you have risk factors like diabetes, metabolic syndrome, obesity, or psoriasis with no fatty liver seen on ultrasound (ultrasound must not show fatty liver).
- You can clearly agree to participate after understanding the study (informed consent).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry collects health and lifestyle information from adults with suspected or confirmed fatty liver (NAFLD) to help researchers better understand the condition. You may be asked about diet, exercise, alcohol intake, and some liver-related tests.
This study collects health information from people with non-alcoholic fatty liver disease (NAFLD), a condition where fat builds up in the liver. It aims to learn more about the disease to improve future care.
This study looks at blood cells and factors in people with metabolic diseases like fatty liver, prediabetes, or type 2 diabetes. It aims to better understand these conditions by comparing them with healthy volunteers.
This study aims to find a simple way to detect liver fibrosis, a condition where the liver becomes scarred, in people who have risk factors like being overweight, having type 2 diabetes, or drinking alcohol heavily. By identifying fibrosis early, it may help prevent more serious liver problems.
This study takes small samples of liver tissue to grow 3D 'mini livers' (organoids) in the lab. Researchers want to learn how non-alcoholic steatohepatitis (NASH), a serious fatty liver condition, starts and progresses, which could lead to better treatments.
This study collects health information and samples from people with non-alcoholic fatty liver disease to better understand the condition. It may help researchers find new ways to diagnose or treat this liver problem.
Hear when a new NAFLD (Nonalcoholic Fatty Liver Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.